Drug Repurposing: Exploring Newer Therapeutic Potentials
Sold by Books Puddle, New York, NY, U.S.A.
AbeBooks Seller since 22 November 2018
New - Hardcover
Condition: New
Ships within U.S.A.
Quantity: 4 available
Add to basketSold by Books Puddle, New York, NY, U.S.A.
AbeBooks Seller since 22 November 2018
Condition: New
Quantity: 4 available
Add to basketThe book explores the field of drug repurposing with a focus on past trends and developments. The book delves into the repurposing of bioactive phytomolecules and their applications in various therapeutic areas, including neurological disorders, diabetes, cardiovascular diseases, and autoimmune conditions. Additionally, it addresses the pressing need for repurposing drugs to combat infectious and neglected diseases, including an in-depth analysis of drug repurposing strategies in the management of COVID-19. Throughout the chapters, readers will find case studies highlighting prominent examples of repurposed drugs, challenges related to regulatory and patent issues, and the role of computational modelling and AI in accelerating drug discovery. This essential resource showcases how drug repurposing revolutionizes modern medicine and fosters a paradigm shift in pharmaceutical research.
The book is a valuable resource for students, researchers, academicians, and pharmacologists.
Dr. Ravinder Kaundal is working as assistant professor at NIPER Raebareli. He has done his MS (Pharm.) and Ph.D. in pharmacology and toxicology from NIPER-SAS Nagar, India. He received his postdoctoral training at Yale School of Medicine, New Haven, and Icahn School of Medicine at Mount Sinai, New York. Dr. Ravinder has made an outstanding contribution to the field of pharmacological research and has elucidated the involvement of various pathogenic pathways like oxidative stress, PARP overactivation, inflammation, and apoptosis in cerebral ischemic-reperfusion injury and diabetic neuropathy. Gene regulation is another of his interests and he has developed various tools/methods to study the mechanisms of epigenetic memory. His work is published in journals of high repute and is highly cited. He is a reviewer and editorial board member of several international journals. Also, his research interests are neuropharmacology, drug repurposing, molecular biology, ischemic-reperfusion injuries, and gene regulation.
Dr. Rahul Shukla, working as assistant professor at Department of Pharmaceutics, NIPER Raebareli, India, did Ph.D. in pharmaceutical sciences from CSIR CDRI and J.N.U New Delhi, India, M Pharm from IIT BHU, Varanasi, India and B. Pharm from Jamia Hamdard, New Delhi. He has the experience of as research scientist at Dr. Reddy's Laboratories, India, and D.S. Kothari Post-Doctoral Fellow at Panjab University, India. He has more than ten years of research and academic experience. He has more than 120 publications including 40 book chapters to his credit. He has filed 9 Patent and 1 Copyright. He was awarded SERB International Research Experience (SIRE) Fellow for the year, 2022-2023 fellowship at School of Pharmacy and Biomedical Sciences, University of Central Lancashire, United Kingdom; He also received Science and Engineering Research Board (SERB) Research Grant. His current research interests include targeted drug delivery systems, particle engineering, controlled and targeted delivery for neurodegenerative diseases and cancer and works on repurposing, particle engineering and bioavailability enhancements.
Prof. Shubhini A. Saraf is working as director of the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli (U.P.). Prior to joining NIPER, Raebareli, she was working as a professor in the Department of Pharmaceutical Sciences and Director (R&D) at Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow. Prof. Shubhini is an alumnus of the Department of Pharmaceutical Sciences, Dr. H.S. Gour University, Sagar, India. She has more than 27 years of teaching and research experience. Her research interests include nanotechnology & drug targeting as well as technology policy interventions for health care. Her work extensively discusses surface-decorated lipid nanoparticles for cancer therapy. She has 165 research papers published in journals of repute. Prof. Shubhini has authored 07 books and 22 chapters. She has attended many national and international conferences and delivered many invited lectures. Her administrative and research work has been recognized at various national and international forums. Prof. Shubhini is a sincere administrator, academician, and researcher and is known for her inclusive involvement and untiring hard work. Her contributions to the pharmacy profession are enormous and praiseworthy.
"About this title" may belong to another edition of this title.
We accept return for those books which are received damamged. Though we take appropriate care in packaing to avoid such situation.
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Books Puddle, New York, New York, U.S.A., without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
| Order quantity | 12 to 19 business days | 12 to 14 business days |
|---|---|---|
| First item | £ 2.96 | £ 5.19 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.